A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough
出版年份 2022 全文链接
标题
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough
作者
关键词
-
出版物
LUNG
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-12-13
DOI
10.1007/s00408-022-00592-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
- (2022) Lorcan P McGarvey et al. LANCET
- Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study
- (2021) Alyn Morice et al. EUROPEAN RESPIRATORY JOURNAL
- Performance of a digital signal processing algorithm for the accurate quantification of cough frequency
- (2021) Jaclyn A. Smith et al. EUROPEAN RESPIRATORY JOURNAL
- The financial burden of treating patients presenting with acute and chronic cough
- (2021) Surinder S. Birring et al. CURRENT MEDICAL RESEARCH AND OPINION
- Discovery of clinical candidate Sivopixant (S-600918): Lead optimization of dioxotriazine derivatives as selective P2X3 receptor antagonists
- (2021) Hiroyuki Kai et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Randomised trial of the P2X3 receptor antagonist sivopixant for refractory chronic cough
- (2021) Akio Niimi et al. EUROPEAN RESPIRATORY JOURNAL
- Chronic cough: new insights and future prospects
- (2021) Alyn Morice et al. European Respiratory Review
- Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Cough and Sputum in Patients with COPD
- (2020) Patrícia Rebelo et al. International Journal of Chronic Obstructive Pulmonary Disease
- Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial
- (2020) Jaclyn A Smith et al. Lancet Respiratory Medicine
- Mechanisms and Rationale for Targeted Therapies in Refractory and Unexplained Chronic Cough
- (2020) Stuart Mazzone et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Effect of Gefapixant, a P2X3 antagonist, on Cough Reflex Sensitivity: A randomised placebo-controlled study
- (2019) Alyn H. Morice et al. EUROPEAN RESPIRATORY JOURNAL
- Clinical impact of gastroesophageal reflux disease in patients with subacute/chronic cough
- (2019) Yoshihiro Kanemitsu et al. ALLERGOLOGY INTERNATIONAL
- ERS guidelines on the diagnosis and treatment of chronic cough in adults and children
- (2019) Alyn H. Morice et al. EUROPEAN RESPIRATORY JOURNAL
- An update and systematic review on drug therapies for the treatment of refractory chronic cough
- (2018) Nicole M. Ryan et al. EXPERT OPINION ON PHARMACOTHERAPY
- Drug-Induced Taste Disorders In Clinical Practice And Preclinical Safety Evaluation
- (2017) Tao Wang et al. TOXICOLOGICAL SCIENCES
- The global epidemiology of chronic cough in adults: a systematic review and meta-analysis
- (2015) Woo-Jung Song et al. EUROPEAN RESPIRATORY JOURNAL
- P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study
- (2015) Rayid Abdulqawi et al. LANCET
- Management of chronic refractory cough
- (2015) Peter G Gibson et al. BMJ-British Medical Journal
- Management of chronic refractory cough
- (2015) Peter G Gibson et al. BMJ-British Medical Journal
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search